Enoxaparin for prevention of unexplained recurrent miscarriage: a multicenter randomized double-blind placebo-controlled trial
Open Access
- 2 April 2015
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 125 (14) , 2200-2205
Abstract
Key Points: The use of low-molecular-weight heparin did not improve live-birth rates in nonthrombophilic women with consecutive recurrent miscarriage. Prophylactic doses of low-molecular-weight heparin should no longer be prescribed in this clinical setting.Keywords
This publication has 35 references indexed in Scilit:
- Increased thrombin generation measured in the presence of thrombomodulin in women with early pregnancy lossFertility and Sterility, 2011
- Thromboprophylaxis for recurrent miscarriage in women with or without thrombophiliaThrombosis and Haemostasis, 2011
- Recurrent MiscarriageNew England Journal of Medicine, 2010
- Diagnostic factors identified in 1020 women with two versus three or more recurrent pregnancy lossesFertility and Sterility, 2010
- RETRACTED ARTICLE: Low-molecular weight heparin in patients with recurrent early miscarriages of unknown aetiologyJournal of Obstetrics and Gynaecology, 2008
- Recurrent miscarriageThe Lancet, 2006
- International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)Journal of Thrombosis and Haemostasis, 2006
- Thrombophilia in pregnancy: a systematic reviewBritish Journal of Haematology, 2005
- A proposed charter for clinical trial data monitoring committees: helping them to do their job wellThe Lancet, 2005
- Therapeutic uses of heparin beyond its traditional role as an anticoagulantTrends in Pharmacological Sciences, 1995